Oveporexton

奥博雷通

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameOveporexton
Drug Alias NameTAK-861
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 2 agonists
TargetsOrexin receptor type 2
Therapy Area/IndicationsNarcolepsyIdiopathic Hypersomnia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[23] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesTakeda Development Center Americas IncTakeda (China) International Trading Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda (China) International Trading Co LtdTakeda Pharmaceuticals USA IncTakeda GmbH +[5] 
Inactive CompaniesN/A
Active IndicationsNarcolepsyIdiopathic Hypersomnia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A